Dumas Dominique, Toriel Jérôme, Heinzer Raphael, Solelhac Geoffroy
Service de pneumologie, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Centre d'investigation et de recherche sur le sommeil, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Rev Med Suisse. 2024 Nov 13;20(895):2104-2109. doi: 10.53738/REVMED.2024.20.895.2104.
Obstructive sleep apnea (OSA) is a frequent pathology with clinical implications. Its comorbidity with the complaint of insomnia is common, and has been increasingly studied in recent years, due to the multiple negative synergies highlighted by these two conditions, notably on all-cause excess mortality, cardiovascular risk, quality of life and sleep, as well as mental health. This comorbidity between insomnia and sleep apnea has recently been referred to as COMISA («co-morbid insomnia and sleep apnea»). In this article, we explore the relationship between OSA and insomnia, as well as its consequences and currently available treatments, through an analysis of the existing literature.
阻塞性睡眠呼吸暂停(OSA)是一种具有临床意义的常见病症。它与失眠主诉的合并症很常见,并且近年来受到越来越多的研究,因为这两种病症之间存在多种负面协同作用,特别是在全因超额死亡率、心血管风险、生活质量和睡眠以及心理健康方面。失眠与睡眠呼吸暂停之间的这种合并症最近被称为COMISA(“合并性失眠和睡眠呼吸暂停”)。在本文中,我们通过对现有文献的分析,探讨OSA与失眠之间的关系、其后果以及目前可用的治疗方法。